Skip to main content
Lincoln Pharmaceuticals ltd. logo

Lincoln Pharmaceuticals ltd. — Investor Relations & Filings

Ticker · LINCOLN ISIN · INE405C01035 LEI · 3358004B6OBJNW8RTT10 BSE.NS Manufacturing
Filings indexed 453 across all filing types
Latest filing 2024-05-17 Regulatory Filings
Country IN India
Listing BSE.NS LINCOLN

About Lincoln Pharmaceuticals ltd.

https://www.lincolnpharma.com/

Lincoln Pharmaceuticals Ltd. focuses on the development, manufacturing, and marketing of a diverse range of therapeutic formulations. The organization operates advanced manufacturing facilities certified by international standards, including WHO-GMP. Its portfolio spans multiple areas such as anti-infectives, cardiovascular, gastrointestinal, respiratory, and pain management. The company is recognized for its research and development initiatives, particularly in Novel Drug Delivery Systems (NDDS). Key offerings include specialized treatments for tinnitus and a wide array of formulations in dosage forms like tablets, capsules, liquid orals, and injectables. It maintains a significant global footprint, supplying products to numerous international markets across Africa, Southeast Asia, and Latin America, supported by a robust distribution network for its extensive healthcare catalog.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings
2024-05-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding Regulation 30 of SEBI (LODR) Regulations, 2015. It mentions the audio recording of a conference call held to present the results for Q4 and the financial year ended March 31, 2024. The letter provides a link to access the recording and requests the exchanges to take the information on record. The document does not contain the transcript or detailed financial data but is an announcement about the availability of the conference call recording. Therefore, it is not a full Call Transcript (CT) but rather a Regulatory Filing (RNS) announcing the conference call recording pursuant to regulatory requirements.
2024-05-16 English
Updates
Regulatory Filings
2024-05-16 English
Dividend Updates
Regulatory Filings
2024-05-16 English
Financial Result Updates
Regulatory Filings
2024-05-16 English
Dividend
Regulatory Filings
2024-05-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.